Peer-influenced content. Sources you trust. No registration required. This is HCN.
JAMA Network
A comprehensive guide from the American Medical Association (AMA), which includes information for those who want to support communities severely impacted by COVID-19, including the how and where to volunteer and all things to consider.
Allergy & Immunology April 13th 2020
Steven A. Pergam, MD, Medical Director for Infection Prevention at Seattle Cancer Care Alliance (SCCA), provides insight on the unique challenges facing oncologists as they fight the COVID-19 pandemic.
Hematology April 6th 2020
Although researchers emphasized more research is necessary, a study in Blood Advances demonstrated that tocilizumab may be an effective treatment for patients with COVID-19 and hematologic malignancies.
Oncology healthcare providers must consider a trio of specific management strategies for their patients during this time, as COVID-19 can be particularly lethal in patients with cancer.
Geriatrics April 6th 2020
According to JAMA Oncology, researchers located in Wuhan, China – the epicenter of the COVID-19 outbreak – there were more coronavirus cases among patients with cancer versus the general public.
Geriatrics March 30th 2020
Despite a small sample size, a recent trial demonstrated hydroxychloroquine treatment’s effect reinforced by azithromycin is significantly associated with viral load reduction/disappearance in COVID-19 patients.
Allergy & Immunology March 30th 2020